The China private equity practice at Morrison Foerster routinely acts on major take-private transactions. It is particularly active in relation to the technology, online gaming, e-commerce, fintech, biotechnology, life sciences, and healthcare sectors. In the firm’s mainland offices, Rongjing Zhao, an April 2023 recruit from Kirkland & Ellis International LLP, advises private equity funds on investments and acquisitions in China and the rest of Asia; Siyu Gao focuses on TMT-related private equity investments and M&A; and Bingye Wu and Bilin Chen both assist with M&A, private equity investments and general corporate matters. Over in Hong Kong, Marcia Ellis is the global co-chair of private equity; while Maureen Ho acts for private equity and real estate funds, as well as financial and corporate investors.
Key clients
- Ark Pacific Capital
- Ally Bridge Group
- Alibaba Group
- Affirma Capital Managers (Singapore) Pte
- Ascendent Capital Partners
- Bain Capital Credit
- BlackRock
- C2 Capital
- Celadon Partners
- Farallon Capital Asia
- GLP
- Intudo Ventures
- Hony Capital
- Macquarie
- PAG
- NewQuest Capital Partners
- Prax Capital
- Princeton Digital Group
- Serenity Capital
- SoftBank Group Corp
- SoftBank Vision Fund
- Vectr Ventures
Work highlights
- Advising Ascendent Capital Partners, a private equity investment management firm focusing on Greater China investment, on its agreement to privatise Hollysys Automation Technologies.
- Advised Ascendent Capital Partners, as an existing investor, on a merger of the core overseas education business of NetDragon Websoft Holdings with Gravitas Education Holdings.
- Advised Celadon Partners on its launch of GeneFab, and advised GeneFab on its acquisition of chemistry, manufacturing and controls capabilities from NASDAQ-listed Senti Biosciences.
Lawyers
Practice head
The lawyer(s) leading their teams.
Marcia Ellis